Current Report

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): November 3, 2010

 

 

Cardinal Health, Inc.

(Exact name of registrant as specified in its charter)

 

 

 

Ohio   1-11373   31-0958666

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

7000 Cardinal Place, Dublin, Ohio 43017

(Address of principal executive offices) (Zip Code)

(614) 757-5000

(Registrant’s telephone number, including area code)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


 

Item 5.07 Submission of Matters to a Vote of Security Holders

Cardinal Health, Inc. (the “Company”) held its 2010 Annual Meeting of Shareholders on November 3, 2010. For more information on the following proposals, see the Company’s proxy statement dated September 15, 2010, the relevant portions of which are incorporated herein by reference.

The shareholders elected the 12 nominees to the Board of Directors, each to serve until the 2011 annual meeting and until his or her successor is duly elected and qualified, and voted as follows:

 

Director    For      Against      Abstained      Broker
Non-votes
 

Colleen F. Arnold

     268,392,397         12,020,732         647,126         30,245,544   

George S. Barrett

     274,538,308         5,830,082         691,865         30,245,544   

Glenn A. Britt

     273,531,000         6,857,988         671,267         30,245,544   

Carrie S. Cox

     266,464,153         13,936,611         659,491         30,245,544   

Calvin Darden

     278,077,053         2,305,306         677,896         30,245,544   

Bruce L. Downey

     278,247,459         2,137,233         675,563         30,245,544   

John F. Finn

     273,509,146         6,891,194         659,915         30,245,544   

Gregory B. Kenny

     273,334,138         7,069,642         656,475         30,245,544   

James J. Mongan, M.D.

     278,212,279         2,180,497         667,479         30,245,544   

Richard C. Notebaert

     277,604,205         2,794,078         661,972         30,245,544   

David W. Raisbeck

     266,418,217         13,829,350         812,688         30,245,544   

Jean G. Spaulding, M.D.

     278,211,005         2,115,711         733,539         30,245,544   

The shareholders ratified the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending June 30, 2011, and voted as follows:

 

For

     306,442,569   

Against

     3,173,032   

Abstained

     1,690,198   

Broker Non-Votes

     0   

The shareholders approved an amendment to the Company’s Restated Code of Regulations allowing the Board of Directors to amend the Restated Code of Regulations, and voted as follows:

 

For

     262,027,805   

Against

     46,527,169   

Abstained

     2,750,825   

Broker Non-Votes

     0   

The shareholders did not approve the shareholder proposal regarding performance-based stock options, and voted as follows:

 

For

     129,420,696   

Against

     147,128,614   

Abstained

     4,510,945   

Broker Non-Votes

     30,245,544   

 

- 2 -


 

The shareholders did not approve the shareholder proposal regarding an amendment to the Restated Code of Regulations to require that the Chairman of the Board be an independent director, and voted as follows:

 

For

     55,292,194   

Against

     224,167,575   

Abstained

     1,600,486   

Broker Non-Votes

     30,245,544   

The shareholders did not approve the shareholder proposal regarding special shareowner meetings, and voted as follows:

 

For

     130,433,623   

Against

     148,511,658   

Abstained

     2,114,974   

Broker Non-Votes

     30,245,544   

Item 9.01 Financial Statements and Exhibits

 

(d) Exhibits

 

  3.2 The Restated Code of Regulations, as amended.

 

- 3 -


 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    Cardinal Health, Inc.
  (Registrant)
Date: November 5, 2010   By:  

/s/ Craig S. Morford

    Name:   Craig S. Morford
    Title:   Chief Legal and Compliance Officer

 

- 4 -


 

EXHIBIT INDEX

 

3.2 The Restated Code of Regulations, as amended.

 

- 5 -